OBJECTIVE: Low BMI is a major risk factor for early mortality among HIV-infected persons starting antiretrovial therapy (ART) in sub-Saharan Africa and the common patient belief that antiretroviral medications produce distressing levels of hunger is a barrier to treatment adherence. We assessed relationships between appetite, dietary intake and treatment outcome 12 weeks after ART initiation among HIV-infected adults with advanced malnutrition and immunosuppression. DESIGN: A prospective, observational cohort study. Dietary intake was assessed using a 24 h recall survey. The relationships of appetite, intake and treatment outcome were analysed using time-varying Cox models. SETTING: A public-sector HIV clinic in Lusaka, Zambia. SUBJECTS: One hundred and forty-two HIV-infected adults starting ART with BMI <16 kg/m2 and/or CD4+ lymphocyte count <50 cells/μl. RESULTS: Median age, BMI and CD4+ lymphocyte count were 32 years, 16 kg/m2 and 34 cells/μl, respectively. Twenty-five participants (18%) died before 12 weeks and another thirty-three (23%) were lost to care. A 500 kJ/d higher energy intake at any time after ART initiation was associated with an approximate 16% reduction in the hazard of death (adjusted hazard ratio = 0.84; P = 0.01), but the relative contribution of carbohydrate, protein or fat to total energy was not a significant predictor of outcome. Appetite normalized gradually among survivors and hunger was rarely reported. CONCLUSIONS: Poor early ART outcomes were strikingly high in a cohort of HIV-infected adults with advanced malnutrition and mortality was predicted by lower dietary intake. Intervention trials to promote post-ART intake in this population may benefit survival and are warranted.
OBJECTIVE: Low BMI is a major risk factor for early mortality among HIV-infectedpersons starting antiretrovial therapy (ART) in sub-Saharan Africa and the common patient belief that antiretroviral medications produce distressing levels of hunger is a barrier to treatment adherence. We assessed relationships between appetite, dietary intake and treatment outcome 12 weeks after ART initiation among HIV-infected adults with advanced malnutrition and immunosuppression. DESIGN: A prospective, observational cohort study. Dietary intake was assessed using a 24 h recall survey. The relationships of appetite, intake and treatment outcome were analysed using time-varying Cox models. SETTING: A public-sector HIV clinic in Lusaka, Zambia. SUBJECTS: One hundred and forty-two HIV-infected adults starting ART with BMI <16 kg/m2 and/or CD4+ lymphocyte count <50 cells/μl. RESULTS: Median age, BMI and CD4+ lymphocyte count were 32 years, 16 kg/m2 and 34 cells/μl, respectively. Twenty-five participants (18%) died before 12 weeks and another thirty-three (23%) were lost to care. A 500 kJ/d higher energy intake at any time after ART initiation was associated with an approximate 16% reduction in the hazard of death (adjusted hazard ratio = 0.84; P = 0.01), but the relative contribution of carbohydrate, protein or fat to total energy was not a significant predictor of outcome. Appetite normalized gradually among survivors and hunger was rarely reported. CONCLUSIONS: Poor early ART outcomes were strikingly high in a cohort of HIV-infected adults with advanced malnutrition and mortality was predicted by lower dietary intake. Intervention trials to promote post-ART intake in this population may benefit survival and are warranted.
Authors: John R Koethe; Benjamin H Chi; Karen M Megazzini; Douglas C Heimburger; Jeffrey S A Stringer Journal: Clin Infect Dis Date: 2009-09-01 Impact factor: 9.079
Authors: Ronald A Cantrell; Moses Sinkala; Karen Megazinni; Sibi Lawson-Marriott; Sierra Washington; Benjamin H Chi; Bushimbwa Tambatamba-Chapula; Jens Levy; Elizabeth M Stringer; Lloyd Mulenga; Jeffrey S A Stringer Journal: J Acquir Immune Defic Syndr Date: 2008-10-01 Impact factor: 3.731
Authors: Laura K Murray; Katherine Semrau; Ellen McCurley; Donald M Thea; Nancy Scott; Mwiya Mwiya; Chipepo Kankasa; Judith Bass; Paul Bolton Journal: AIDS Care Date: 2009-01
Authors: John R Koethe; Anna Lukusa; Mark J Giganti; Benjamin H Chi; Christopher K Nyirenda; Mohammed I Limbada; Yolan Banda; Jeffrey S A Stringer Journal: J Acquir Immune Defic Syndr Date: 2010-04-01 Impact factor: 3.731
Authors: Elvin H Geng; David R Bangsberg; Nicolas Musinguzi; Nneka Emenyonu; Mwebesa Bosco Bwana; Constantin T Yiannoutsos; David V Glidden; Steven G Deeks; Jeffrey N Martin Journal: J Acquir Immune Defic Syndr Date: 2010-03 Impact factor: 3.731
Authors: A P Hardon; D Akurut; C Comoro; C Ekezie; H F Irunde; T Gerrits; J Kglatwane; J Kinsman; R Kwasa; J Maridadi; T M Moroka; S Moyo; A Nakiyemba; S Nsimba; R Ogenyi; T Oyabba; F Temu; R Laing Journal: AIDS Care Date: 2007-05
Authors: Asgeir Johannessen; Ezra Naman; Bernard J Ngowi; Leiv Sandvik; Mecky I Matee; Henry E Aglen; Svein G Gundersen; Johan N Bruun Journal: BMC Infect Dis Date: 2008-04-22 Impact factor: 3.090
Authors: Muktar H Aliyu; Meridith Blevins; Deidra D Parrish; Karen M Megazzini; Usman I Gebi; Mukhtar Y Muhammad; Mukhtar L Ahmed; Adiba Hassan; Bryan E Shepherd; Sten H Vermund; C William Wester Journal: J Acquir Immune Defic Syndr Date: 2014-02-01 Impact factor: 3.731
Authors: Hubaida Fuseini; Ben A Gyan; George B Kyei; Douglas C Heimburger; John R Koethe Journal: Curr HIV/AIDS Rep Date: 2021-02-19 Impact factor: 5.071
Authors: Andrea M Rehman; Susannah Woodd; George PrayGod; Molly Chisenga; Joshua Siame; John R Koethe; Douglas C Heimburger; Paul Kelly; Henrik Friis; Suzanne Filteau Journal: J Acquir Immune Defic Syndr Date: 2015-04-01 Impact factor: 3.731